Chronic Kidney Disease
Chronic Kidney Disease
Part of NephTimes
Advertisement
Charlotte RobinsonAnemia and Kidney Disease | July 15, 2024
Akebia Therapeutics has ended its license agreement with CSL Vifor for Vafseo and announced WAC pricing for the anemia drug.
Read More
Charlotte RobinsonChronic Kidney Disease | June 27, 2024
Novo Nordisk stopped the phase 3 CLARION-CKD trial of ocedurenone due to disappointing results.
Charlotte RobinsonAnemia and Kidney Disease | June 25, 2024
Iron replacement with ferric citrate hydrate decreased cFGF23 and normalized platelet count with anemia regardless of CKD.
Charlotte RobinsonChronic Kidney Disease | June 21, 2024
Black adults have higher hazards of progression to kidney failure and lower hazards of competing risk of death.
Charlotte RobinsonChronic Kidney Disease | June 20, 2024
Kidney care providers can play a role in depression screening and help improve outcomes for patients with CKD.
Charlotte RobinsonChronic Kidney Disease | June 18, 2024
Humana issued an issue brief focusing on the benefits of value-based care in nephrology.
Charlotte RobinsonChronic Kidney Disease | June 14, 2024
The International Society of Nephrology and WHO brought stakeholders together to discuss global disparities in kidney care.
Charlotte RobinsonChronic Kidney Disease | June 10, 2024
Long-term exposure to ozone is associated with an increased risk of ESRD and mortality in chronic kidney disease.
Charlotte RobinsonChronic Kidney Disease | June 7, 2024
The Congressional Kidney Caucus and kidney organizations are calling for federal screening recommendations for CKD.
Charlotte RobinsonChronic Kidney Disease | May 22, 2024
Whether ULT should be used in CKD patients with asymptomatic hyperuricemia to prevent the progression of CKD is uncertain.
Charlotte RobinsonGout | May 20, 2024
Recognizing and managing concurrent gout and CKD is important for improving outcomes but can be difficult.
Victoria SochaChronic Kidney Disease | May 9, 2024
There are few data on whether finerenone-induced change in UACR mediates cardiovascular and kidney failure outcomes.
Charlotte RobinsonChronic Kidney Disease | May 8, 2024
AI technology to detect elevated CKD risk in people with diabetes received Breakthrough Device designation from the FDA.
Victoria SochaChronic Kidney Disease | May 8, 2024
How does sodium bicarbonate affect bone health markers in patients with chronic kidney disease (CKD)?
Charlotte RobinsonChronic Kidney Disease | May 1, 2024
Researchers explored the association between CSVD and CKD plus the potential role of hypertension in this association.
Charlotte RobinsonDiabetes and Hypertension | May 2, 2024
Researchers examined use of clinical decision support systems to decrease blood pressure in hypertensive patients with CKD.
Charlotte RobinsonAnemia and Kidney Disease | April 26, 2024
Researchers examined the roles of hyperuricemia and anemia in all-cause mortality with chronic kidney disease (CKD).
Charlotte RobinsonAnemia and Kidney Disease | April 25, 2024
The ERA reviewed phase 3 trials to clarify the mechanism behind HIF-PHi and their role in managing CKD-related anemia.
Charlotte RobinsonHyperkalemia | April 24, 2024
Research has begun to question recommendations to restrict potassium with CKD to manage hyperkalemia.
Charlotte RobinsonWCN 2024 | April 20, 2024
A super-learner strategy gave accurate risk predictions of kidney failure and death for people with moderate to severe CKD.
Advertisement
Advertisement
Advertisement
Latest News

July 16, 2024